(Q35837384)

10 August 2017

NOD2 polymorphism predicts response to treatment in Crohn's disease--first steps to a personalized therapy (English)

1 reference

10 August 2017

0 references

Jan Hendrik Niess

1

1 reference

10 August 2017

Jochen Klaus

2

1 reference

10 August 2017

Johannes Stephani

3

1 reference

10 August 2017

Carolin Pflüger

4

1 reference

10 August 2017

Nadine Degenkolb

5

1 reference

10 August 2017

Ulrike Spaniol

6

1 reference

10 August 2017

Benjamin Mayer

7

1 reference

10 August 2017

Georgia Lahr

8

1 reference

10 August 2017

Georg B T von Boyen

9

1 reference

10 August 2017

7 December 2011

1 reference

Digestive Diseases and Sciences

10 August 2017

1 reference

10 August 2017

57

1 reference

10 August 2017

4

1 reference

10 August 2017

879-886

1 reference

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Inflammatory bowel disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Genetic risk profiling and prediction of disease course in Crohn's disease patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Clinical practice guideline on diagnosis and treatment of Crohn's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Unravelling the pathogenesis of inflammatory bowel disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Recent advances in the genetics of inflammatory bowel disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

The molecular classification of the clinical manifestations of Crohn's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Review article: the limitations of corticosteroid therapy in Crohn's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

A controlled double blind study of azathioprine in the management of Crohn's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

National Cooperative Crohn's Disease Study: results of drug treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Selection criteria for preoperative endoscopic retrograde cholangiopancreatography before laparoscopic cholecystectomy and endoscopic treatment of bile duct stones: results of a retrospective, single center study between 1996-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306782

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

24 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Polymorphisms of Tumor Necrosis Factor-α but Not MDR1 Influence Response to Medical Therapy in Pediatric-Onset Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1977-3

Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy

21 January 2018

1 reference

12 December 2020

Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease

1 reference

12 December 2020

Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes

1 reference

12 December 2020

European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment

1 reference

12 December 2020

Predictors of Crohn's disease

1 reference

12 December 2020

Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis

1 reference

12 December 2020

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

12 December 2020

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study

1 reference

12 December 2020

10.1007/S10620-011-1977-3

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22147245

1 reference